Key insights
- The article discusses potential volatility in Bayer's stock (BAYN) due to an upcoming Supreme Court hearing regarding Roundup lawsuits and the expiration of a truce related to Iran. While the author anticipates short-term price fluctuations driven by these events, the Supreme Court's perceived favor towards Bayer could lead to a stock re-rating later in the year. The Iran truce is a geopolitical risk factor.
$XETR:BAYN experiencing relief from Trumps 2-week truce due to a cost-of-business break and general optimism.
Iran Truce Ends: Tuesday, April 21, 2026.
SCOTUS Hearing: Monday, April 27, 2026.
This creates a window of anxiety in about two weeks. When the pause expires, if a peace deal isn't signed, the bombing threat returns at the same time the Supreme Court begins the Roundup hearing.
Forecast: expect high volatility. The market will be anxious of both the war and the court.
Broad timeline & price movement forecast:
April 8 – April 15: Price drifts up (estimates: €41–€43).
April 16 – April 21: Price drifts down as the pause deadline nears (estimates: €39–€41).
April 21 – April 24: Price whiplash as hedge funds reposition, potentially washing out weak conviction and retail traders.
I will be following events (as permanent peace deal before the 21st) but estimate a buy limit of ~€37.50 - matching CEO's previous purchase.
Supreme Court generally appears to favour Bayer. Stock may rerate and price move towards the summer.